AGC Biologics Appoints David Stewart as the New General Manager/Site Head of the Boulder, Colorado Site
USA - English
Share this article
Share this article
BOULDER, Colo., Jan. 21, 2021 /PRNewswire/ AGC Biologics, a leading global Biopharmaceutical Contract Development and Manufacturing Organization (CDMO), has announced a new appointment to oversee the startup, strategic development and operational excellence in large-scale biologics production at its Boulder, Colorado site. Effective February 1, 2021, David Stewart will join the Boulder team as the General Manager/Site Head.
Mr. Stewart brings a servant leader mindset, with a proven record of delivering best-in-class supply for client organizations and the patients they serve. He promotes accountability, innovation, collaboration, and agility to build high-performance teams. He also brings more than 20 years of leadership experience in the biotechnology and manufacturing industry, including roles with Biogen and Genentech.
Pierre Fabre wählt AGC Biologics als CDMO zur Herstellung des Orphan Drugs ER-004
finanznachrichten.de - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from finanznachrichten.de Daily Mail and Mail on Sunday newspapers.
Börse Express - Pierre Fabre wählt AGC Biologics als CDMO zur Herstellung des Orphan Drugs ER-004
boerse-express.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from boerse-express.com Daily Mail and Mail on Sunday newspapers.
Pierre Fabre wählt AGC Biologics als CDMO zur Herstellung des Orphan Drugs ER-004
prnewswire.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from prnewswire.com Daily Mail and Mail on Sunday newspapers.